Subtype
Pancreatic Adenocarcinoma
CI-CAN-00006283Explore in graph →
356 active trials5 approved drugs26 evidence items
- NCIt
- C8294
- OncoTree
- PAAD
- DOID
- 4074
- UMLS CUI
- C0281361
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00006283Explore in graph →
Clinical trials
915 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (136)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07799298 | Spleen Preservation Versus Splenectomy in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)(SPLENDID RCT) | not yet recruiting | N/A | 360 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07787156 | Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial(REGENERATE) | not yet recruiting | N/A | 80 | Brigham and Women's HospitalOTHER |
| 1 |
| Aug 26, 2026 |
| clinicaltrials |
| NCT07592819 | A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC)(PRODIGE 104 B) | not yet recruiting | N/A | 367 | Institut Paoli-CalmettesOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07547033 | Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy(EQUINOXE) | not yet recruiting | N/A | 150 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT06655142 | OSCAR II STUDY - The ONCObind CTC Removal Study | not yet recruiting | N/A | 120 | ExThera Medical CorporationINDUSTRY | 0 | Apr 17, 2026 | clinicaltrials |
| NCT07516392 | Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma(PRE-PDAC) | not yet recruiting | N/A | 1,140 | Catholic University of the Sacred HeartOTHER | 0 | Apr 8, 2026 | clinicaltrials |
| NCT06958224 | Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers(ESCAT) | not yet recruiting | N/A | 360 | University Hospital, LilleOTHER | 0 | Feb 20, 2026 | clinicaltrials |
| NCT07093593 | Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs(RAMA) | not yet recruiting | N/A | 260 | Centre Georges Francois LeclercOTHER | 0 | Jul 30, 2025 | clinicaltrials |
| NCT07014254 | Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies | not yet recruiting | N/A | 20 | Xijing HospitalOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT06911021 | 68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma | not yet recruiting | N/A | 20 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06743386 | Pilot Study of EUS-Guided Radiofrequency and FOLFIRINOX in Advanced Pancreatic Cancer (RadioFAP )(RadioFAP) | not yet recruiting | N/A | 30 | French Society of Digestive EndoscopyOTHER | 0 | Mar 11, 2025 | clinicaltrials |
| NCT06272162 | Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy(LAPSTAR) | not yet recruiting | N/A | 150 | UMC UtrechtOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT05611359 | Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer(HOPE-1) | not yet recruiting | N/A | 60 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Nov 10, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Sep 2, 2026source: clinicaltrials